At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Propranolol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Combined Effects of Early Behavioral Intervention and Propranolol on ASD
In Brief
A clinical study evaluating Propranolol and Placebo for Autism. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to explore the effects of propranolol in combination with early intensive behavioral intervention on social interaction, and secondarily on language, anxiety, adaptive behaviors, and global function in children with autism in a double-blinded, placebo-controlled pilot trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutism
CountriesUnited States
CollaboratorsAutism Science Foundation
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartApr 2015
First PostedApr 2015
Primary CompletionNov 2022
TodayJul 2026
First PostedApr 28, 2015
Enrollment StartApr 1, 2015
Primary CompletionNov 1, 2022
TodayJul 2, 2026
Enrollment to primary: 7.6 yearsPosted 11.2 years ago
Interventions
Propranololdrug
Participant will receive Propranolol prior to each EIBI session
Placebodrug
Participant will receive placebo prior to each EIBI session